Current Psychopharmacology
Title:Editorial (Thematic Issue:Classic and New Agents to the Treatment of Affective Disorders: Some Concerns and Perspectives
Volume: 4
Author(s): Mónica Flores-Ramos and Claudia Becerra-Palars
Affiliation:
Export Options
About this article
Cite this article as:
Flores-Ramos Mónica and Becerra-Palars Claudia, Editorial (Thematic Issue:Classic and New Agents to the Treatment of Affective Disorders: Some Concerns and Perspectives, Current Psychopharmacology 2015; 4 (2) . https://dx.doi.org/10.2174/221155600402160201131634
DOI https://dx.doi.org/10.2174/221155600402160201131634 |
Print ISSN 2211-5560 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-5579 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Modeling of Dopamine D2 Receptor - Overview of 35-Year Evolution
Current Medicinal Chemistry The Role of Biomechanical Factors on Patellofemoral Osteoarthritis
Current Rheumatology Reviews Editorial [Hot Topic: New Prospects for Treatment of Autoimmune Diseases (Executive Guest Editor: Alessandra Fierabracci)]
Current Pharmaceutical Design Serum β-Amyloid Peptide Levels Spike in the Early Stage of Alzheimer- Like Plaque Pathology in an APP/PS1 Double Transgenic Mouse Model
Current Alzheimer Research Neurobiology of Sleep Disturbances in Neurodegenerative Disorders
Current Pharmaceutical Design Pain and Obesity in the Older Adult
Current Pharmaceutical Design Interplay between Catalysts and Substrates for Activity of Class Ib Aminoacyl-tRNA Synthetases and Implications for Pharmacology
Current Topics in Medicinal Chemistry RNAi for the Treatment of Prion Disease: A Window for Intervention in Neurodegeneration?
CNS & Neurological Disorders - Drug Targets Physical Therapy Modalities in Management of Fibromyalgia
Current Pharmaceutical Design Epidemiology and Risk Factors of Cerebral Ischemia and Ischemic Heart Diseases: Similarities and Differences
Current Cardiology Reviews AMPK as a Potential Anticancer Target - Friend or Foe?
Current Pharmaceutical Design The Role of Adenosine in the Regulation of Sleep
Current Topics in Medicinal Chemistry Editorial [Hot Topic: Drug Addiction and Brain Targets: From Preclinical Research to Pharmacotherapy (Guest Editor: Shafiqur Rahman)]
CNS & Neurological Disorders - Drug Targets A Computational View of COX-2 Inhibition
Anti-Cancer Agents in Medicinal Chemistry Calcium-engaged Mechanisms of Nongenomic Action of Neurosteroids
Current Neuropharmacology Increasing Hippocampal Neurogenesis: A Novel Mechanism for Antidepressant Drugs
Current Pharmaceutical Design Cannabinoids and Neuroprotection in Motor-Related Disorders
CNS & Neurological Disorders - Drug Targets Encapsulation in Cell Therapy: Methodologies, Materials, and Clinical Applications
Current Pharmaceutical Biotechnology Commentary (Research Highlights)
CNS & Neurological Disorders - Drug Targets The Diagnosis of Drug-Induced Liver Disease
Current Clinical Pharmacology